Patent · US Active

Rhinovaccination system of influenza vaccine

US11103453B2 · kind B2 · utility

0Cited by
5References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 24, 2015
Grant dateAug 31, 2021
Priority date
Expiry dateJul 1, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/16134
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a rhinovaccination system of influenza vaccine, comprising a medical syringe filled with an influenza vaccine composition which comprises an inactivated whole influenza virion and a gel base material comprising carboxy vinyl polymer to administer the influenza vaccine composition to nasal mucosa, which is characterized by not comprising an adjuvant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.